Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...

JERUSALEM (Reuters) - Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in ...

Operator Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported third-quarter 2024 sales of $4.33 billion on Wednesday. It beat the ...

Teva Pharmaceuticals' strategic turnaround delivers massive gains--13% revenue jump and higher 2024 guidance ignite market ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Sees FY24 capital expenditures $500M. Sees FY24 free cash flow $1.7B-$2B. Says on track for FY27 targets. Guidance taken from Q3 earnings ...

Teva Pharmaceutical (TEVA) stock gains in premarket after the company posted better than expected Q3 2024 financials and ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...

Teva Pharmaceutical Industries Ltd. has been fined nearly €463 million ($503 million) by the European Union’s antitrust ...